WS
IDXG

Wedbush Securities’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

Wedbush Securities’s Portfolio IDXG Stock Details IDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,661
Closed -$13K – 1050
2019
Q4 		$13K Buy
+2,661
New +$17.2K ﹤0.01% 986
2018
Q3 		– Sell
-1,600
Closed -$14K – 956
2018
Q2 		$14K Sell
1,600
-3,700
-70% -$32.8K ﹤0.01% 872
2018
Q1 		$47K Sell
5,300
-1,100
-17% -$11.3K 0.01% 784
2017
Q4 		$65K Buy
6,400
+4,900
+327% +$59.2K 0.01% 814
2017
Q3 		$23K Sell
1,500
-3,750
-71% -$44.3K ﹤0.01% 822
2017
Q2 		$47K Buy
+5,250
New +$103K 0.01% 805

Other funds holding IDXG

PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.6B AUM 15.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return